Targeting overactive immune cells with experimental drug could improve TBI symptoms

Targeting overactive immune cells with experimental drug could improve TBI symptoms

Targeting overactive immune cells with experimental drug could improve TBI symptoms

Researchers at the University of Maryland School of Medicine found that targeting overactive immune cells in the brain with an experimental drug could limit brain cell loss and reverse cognitive and motor difficulties caused by traumatic brain injury.